Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
Clinical trial NCT05671822 · RECRUITING
Trial details
- NCT number
- NCT05671822
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2027-12-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.